Planet Labs PBC stock
PLNYSEIndustrialsISIN US72703X1063
36Score 36 out of 100, Weak
Price and trend
42 / 100
Price history
+12% in one yearThe chart shows daily closes over 6 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 47% below it.
Since August 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 53).
The price is 73% below its 52-week high. Largest decline in 6 years: 86% (November 2021 to April 2024).
Chart figures for advanced users
- SMA 50$15.48
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$26.10
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)53
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$11.16
- The lowest closing price of the last twelve months.
- Resistance$51.40
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Planet Labs PBC belongs to the Aerospace & Defense industry (United States) and, with a market value of $4.73B, is number 74 of 114 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $307.73M (up 25.9% year on year) and a loss of $246.86M.
- For fiscal 2027, analysts expect on average revenue of $437.84M (up 42.3%) and adjusted earnings per share of −$0.05.
Show more
- MEQIRI Score 36 out of 100 (Weak): rank 964 of 1023 in Industrials, median 61.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 22.1% a year since 2021, Aerospace & Defense median 10.6%.Growth 70
- More cash than debtCash $865.42M, financial debt $448.26M.
Weaknesses
- Loss-makingLoss of $359.87M over the last 12 months.Fundamentals 17
- Volatile share priceVolatility 95% a year over the last 12 months.Stability 45
- DilutionShare count up 17% since 2022.Capital allocation 18
Its standout strength is growth, while capital allocation and fundamentals hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredClosing price of 11 Nov 2026, used by the daily score.
A fair value is not meaningful here, so the signal follows the valuation grade.
Valuation metrics
The model puts the fair value at less than a quarter of the share price. That says more about the assumptions than about the company, so a fair value is not meaningful here and the valuation relies on the P/E and the other metrics.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 31 Jul 2026, revenue rose 44.1% on the twelve months before. Revenue has grown strongly since 2020, at around 21% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 56%, operating −31%, net −80%. Last 12 months: net −95%.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 10 Dec 2026in 28 days
- Last reported
- 3 Sep 2026EPS reported $0.02 (expected −$0.02)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- −$0.05+0.1%
- Revenue
- $437.84M0.0%
- Earnings per share
- $0.010.0%
- Revenue
- $571.25M+0.3%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −9.4%Low end of the full-year guidance raised: gross margin of 55% to 57% (above the prior high end) and adjusted EBITDA of $3 million to $10 million.
“We are similarly increasing the low end of our guidance range for adjusted EBITDA to reflect the improvement in margins with a current forecast between $3 million and $10 million, reflecting our resolve to drive adjusted EBITDA profitability on an annual basis as we capture market share through advancing our …”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 3 Sep 2026 (fiscal Q2 2027), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 6 insiders sold, $14.1M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Robinson KristenSale
15 Oct 2026, Board
- Shares
- 40,000
- Price
- $14.14
- Value
- $565,560
- Raymond John wSale
13 Oct 2026, Board
- Shares
- 6,494
- Price
- $15.23
- Value
- $98,893
- Brennan Ita MSale
1 Oct 2026, Board
- Shares
- 11,500
- Price
- $16.30
- Value
- $187,479
Show 8 more
- Johnson Ashley F.Sale
17 Sept 2026, President & CFO
- Shares
- 55,663
- Price
- $16.96
- Value
- $944,312
- Schingler Robert HSale
17 Sept 2026, Co-Founder Chief Strategy Off.
- Shares
- 52,240
- Price
- $16.96
- Value
- $886,225
- Johnson Ashley F.Sale
23 Jul 2026, President & CFO
- Shares
- 110,028
- Price
- $22.08
- Value
- $2.43M
- Robinson KristenSale
15 Jul 2026, Board
- Shares
- 37,107
- Price
- $25.05
- Value
- $929,638
- Raymond John wSale
13 Jul 2026, Board
- Shares
- 6,494
- Price
- $26.16
- Value
- $169,871
- Schingler Robert HSale
10 Jul 2026, Co-Founder Chief Strategy Off.
- Shares
- 89,593
- Price
- $25.92
- Value
- $2.32M
- Marshall William SpencerSale
10 Jul 2026, Co-Founder and CEO
- Shares
- 200,000
- Price
- $25.92
- Value
- $5.18M
- Brennan Ita MSale
1 Jul 2026, Board
- Shares
- 11,500
- Price
- $33.00
- Value
- $379,475
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Planet Labs PBC
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
1023 rated companies in Industrials
- This company
- 36
- Sector median
- 61
Categories against the sector medianMedian of 1,023 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Aerospace & Defense
The next larger and next smaller companies by market value
- Mercury SystemsMRCY $5.38B39
- FincantieriFCT.MI $5.1B40
- MDA SpaceMDA $5.02B49
- OHBOHB.DE $4.89B48
- AARAIR $4.59B63
- Firefly AerospaceFLY $4.45B41
- RENK GroupR3NK.DE $3.8B56
- Archer AviationACHR $3.74B35
ETFs that hold Planet Labs PBC
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Invesco Defence Innovation UCITS ETF AccumUSDIVDF | 1.30% | 0.35% | €134.79M |
| VanEck Defense UCITS ETFDFEN | 0.89% | 0.55% | €5.85B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.05% | 0.43% | €2.48B |
Show 5 more
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.04% | 0.35% | €434.1M |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.03% | 0.45% | €1.53B |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €175.89M |
| Vanguard ESG Global All Cap UCITS ETF (USD) AccumulatingV3AA | 0.00% | 0.24% | €1.69B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Jan 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 27 Mar 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.